AI
Tuesday, March 06, 2018 10:08:59 PM
$ETBI: NEXT BIG OTC BIOTECH RUNNER
52 WEEK HIGH=.045, CURRENTLY ONLY .0042 HUGE UPSIDE!
NON-DILUTIVE FINANCING, CLEAN LEVEL II
$ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
RECENT NEWS
EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients
ACCESSWIRE | 03/05/2018
Eastgate Biotech Provides Corporate Update
ACCESSWIRE | 03/01/2018
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
52 WEEK HIGH=.045, CURRENTLY ONLY .0042 HUGE UPSIDE!
NON-DILUTIVE FINANCING, CLEAN LEVEL II
$ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
RECENT NEWS
EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients
ACCESSWIRE | 03/05/2018
Eastgate Biotech Provides Corporate Update
ACCESSWIRE | 03/01/2018
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
"Well, life all comes down to a few moments, this is one of them."
Disclaimer: Anything I write here is Just My Opinion
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
